| David H Richman, MD | |
|
109 Commercial St, Hallmark Health Medical Associates, Malden, MA 02148-5509 | |
| (781) 388-4160 | |
| (781) 397-8715 |
| Full Name | David H Richman |
|---|---|
| Gender | Male |
| Speciality | Obstetrics & Gynecology |
| Location | 109 Commercial St, Malden, Massachusetts |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285623645 | NPI | - | NPPES |
| B30165 | Other | MA | BLUE CROSS LEGACY PROVIDER # |
| 0193623 | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 47899 (Massachusetts) | Primary |
| Entity Name | Hallmark Health Medical Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770563900 PECOS PAC ID: 4385638782 Enrollment ID: O20040409000006 |
News Archive
M-3 Information entered the smart phone application environment by offering the M-3 Checklist, a scientifically validated screen for depression and anxiety disorders, at the iTunes store on Friday, April 30, 2010. Adapted from M-3 Information's existing mymoodmonitor.com website, this mobile version, called mym3, provides the same validated mental health questionnaire optimized for smart phones. A first in iPhone applications, mym3 is designed to create a bridge between user responses and recommendations set forth in the content-rich M3 website application.
The sex hormone estrogen tempers the killing activity of a specific group of immune cells, the cytotoxic T cells (CTLs), which are known to attack tumor cells and cells infected by viruses. The key player in this process is a cytotoxic T cell molecule which has been known for a long time and which scientists have named EBAG9.
A researcher at the University of Virginia School of Medicine has magnified a benefit of exercise in mice to provide a "profound" protection from diabetic cardiomyopathy, a potentially deadly heart condition that affects many people with diabetes. The discovery demonstrates the power of exercise to prevent chronic health conditions and suggests that one day some benefits of exercise may come in a pill or bottle.
Nanobiotix, a company developing novel cancer nanotherapeutics, announced today that its lead compound NBTXR3 has received the formal authorization from the French Medicine Agency, AFSSAPS, to start the first clinical trial.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David H Richman, MD 109 Commercial St, Hallmark Health Medical Associates, Malden, MA 02148-5509 Ph: (781) 388-4160 | David H Richman, MD 109 Commercial St, Hallmark Health Medical Associates, Malden, MA 02148-5509 Ph: (781) 388-4160 |
News Archive
M-3 Information entered the smart phone application environment by offering the M-3 Checklist, a scientifically validated screen for depression and anxiety disorders, at the iTunes store on Friday, April 30, 2010. Adapted from M-3 Information's existing mymoodmonitor.com website, this mobile version, called mym3, provides the same validated mental health questionnaire optimized for smart phones. A first in iPhone applications, mym3 is designed to create a bridge between user responses and recommendations set forth in the content-rich M3 website application.
The sex hormone estrogen tempers the killing activity of a specific group of immune cells, the cytotoxic T cells (CTLs), which are known to attack tumor cells and cells infected by viruses. The key player in this process is a cytotoxic T cell molecule which has been known for a long time and which scientists have named EBAG9.
A researcher at the University of Virginia School of Medicine has magnified a benefit of exercise in mice to provide a "profound" protection from diabetic cardiomyopathy, a potentially deadly heart condition that affects many people with diabetes. The discovery demonstrates the power of exercise to prevent chronic health conditions and suggests that one day some benefits of exercise may come in a pill or bottle.
Nanobiotix, a company developing novel cancer nanotherapeutics, announced today that its lead compound NBTXR3 has received the formal authorization from the French Medicine Agency, AFSSAPS, to start the first clinical trial.
› Verified 6 days ago
Sylvia Cho, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 109 Commercial St, Malden, MA 02148 Phone: 781-388-4160 Fax: 781-397-8715 | |
Dr. Melanie Russell Blackstock, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 109 Commercial St, Malden, MA 02148 Phone: 781-388-4160 Fax: 781-397-8715 | |
May-tal Sauerbrun-cutler, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 109 Commercial St, Malden, MA 02148 Phone: 781-338-4160 Fax: 781-397-8715 |